Demant A/S

Equities

DEMANT

DK0060738599

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 15:59:31 30/04/2024 BST			5-day change	1st Jan Change
336.4 ^DKK	-1.35%		+4.21%	+13.65%

04-08	Denmark's Demant Finalizes Capital Reduction	MT
04-04	Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	MT

Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.

February 07, 2023 at 02:58 am

From July 1, 2022 to December 31, 2022, the company has repurchased 2,402,539 shares, representing 1.05% for DKK 533 million. With this, the company has completed the repurchase of 17,002,501 shares, representing 7.24% for DKK 5,040 million under the buyback announced on March 5, 2021.

Latest news about Demant A/S

Denmark's Demant Finalizes Capital Reduction	04-08	MT
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04-04	MT
Demant Seeks Acquisitions	03-12	CI
Transcript : Demant A/S - Analyst/Investor Day	03-12
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss	02-28	DJ
Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S	02-07	CI
Nordic Shares Rose Tuesday; Demant Climbed Highest	02-06	DJ
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024	02-06
Global markets live: BP, Palantir, Infineon, Toyota, UBS...	02-06
Transcript : Demant A/S, 2023 Earnings Call, Feb 06, 2024	02-06
US Futures Mixed, European Stocks Rise as Investors Parse More Fedspeak	02-06	DJ
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	02-06	CI
Demant A/S Reports Earnings Results for the Full Year Ended December 31, 2023	02-06	CI
Demant Forecasts Up to 8% Organic Revenue Growth in FY24	02-06	MT
Demant to Explore Strategic Options for Communications Business Amid Weak Market Conditions	02-05	MT
Demant A/S Provides Earnings Guidance for the Year 2024	02-05	CI
Demant A/S Promotes Peter Pudselykke as Head of Investor Relations Effective 1 March 2024	01-03	CI
Demant to Recommence Share Buybacks	11-21	MT
Nordic Stocks Dropped Tuesday; Demant Took Biggest Hit	11-07	DJ
DEMANT : Sales broadly in-line; guidance narrowed	11-07
Transcript : Demant A/S, Q3 2023 Interim Management Statement Call, Nov 07, 2023	11-07
US Futures Slip, European Stocks Mostly Flat	11-07	DJ
Demant Q3 revenue meets forecast, narrows outlook	11-07	RE
Demant A/S Provides Earnings Guidance for the Year 2023	11-07	CI
European Commission OKs Cochlear's Aquisition of Oticon Medical Unit	10/10/23	MT

Chart Demant A/S

Duration

Period

More charts

Company Profile

Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

05/05/2024 - Q1 2024 Sales and Revenue Release - Interim Management Statement

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DEMANT : In-line Q4; markets cheer the promising takeaways for 2024

February 06, 2024 at 05:46 pm

More Strategies

Ratings for Demant A/S

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

341 DKK

Average target price

334.8 DKK

Spread / Average Target

-1.83%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
DEMANT A/S	+13.65%	10.67B
SONOVA HOLDING AG	-6.92%	16.91B
COCHLEAR LIMITED	+8.85%	13.91B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-13.54%	2.1B
EMBLA MEDICAL HF.	+5.65%	1.82B
ANGELALIGN TECHNOLOGY INC.	+39.70%	1.72B
MODERN DENTAL GROUP LIMITED	+12.09%	579M
ANGEL ROBOTICS CO., LTD.	0.00%	427M
DELCATH SYSTEMS, INC.	+25.00%	133M
INTEGRUM AB	+25.30%	98.18M

Medical Prosthetics